View drug registration information details.
Items | Registration information |
ID | 323 |
No | 323 |
Brand Name | KETOCONAZOLE TABLET 200 MG |
Ingredients | KETOCONAZOLE 200 MG |
Dosage Form | TABLET |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 30 C, PROTECT FROM LIGHT |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | J02AB02 |
Pharmaceutical Class | ANTIFUNGAL |
Indications | TREATMENT OF THE FOLLOWING SYSTEMIC FUNGAL INFECTIONS IN PATIENTS WHO HAVE FAILED OR WHO ARE INTOLERANT TO OTHER THERAPIES:BLASTOMYCOSIS, COCCIDIOIDOMYCOSIS, HISTOPLASMOSIS, CHROMOMYCOSIS AND PARACOCCIDIOIDOMYCOSIS |
Contraindications | IN PATIENTS WITH ACUTE OR CHRONIC LIVER DISEASE OR WITH A KNOWN HYPERSENSITIVITY, WHEN CO-ADMINISTERED WITH TERFENADINE, ASTEMIZOLE AND CISAPRIDE. |
Side Effects | HEPATITIS, HYPERSENSITIVITY, SKIN RASH, PRURITUS, DIARRHEA, NAUSEA, VOMITTING, CONSTIPATION, ABDOMINAL PAIN, DIZZINESS, DROWNSINESS, HEADACHE, GYNAECOMASTIA, IMPOTENCE, MENSTRUAL IRREGULARITIES, PHOTOPHOBIA, SOMNOLENCE, THROMBOCYTOPENIA, |
Unit Price | 6.1 |
EDL |
Yes |
Description | ROUND, 10 MM IN DIAMETER, WHITE UNCOATED TABLET, BEVEL-EDGED, SHALLOW CONVEX FACES, HD AND BREAK-BAR EMBOSSED ON ONE FACE |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL19987375AZ |
Import Registration Date | 28/09/2013 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-03-29 |
FDD Registration No | 05 I 4705/19 |
FDD Registration Date | 2022-09-08 |
Expiry Date | 2025-09-07 |
Back to drug list
|